Thomas Danne Selected Research

Insulin Aspart (NovoLog)

1/2021	Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study.
1/2020	The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes.
1/2020	Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
1/2019	The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials.
1/2019	Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.
12/2017	Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.
1/2017	A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes.
5/2015	Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes.
10/2007	Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
8/2003	A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Danne Research Topics

Disease

92	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2002
34	Hypoglycemia (Reactive Hypoglycemia) 10/2022 - 08/2003
17	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 09/2013
14	Type 2 Diabetes Mellitus (MODY) 10/2022 - 02/2006
9	Hyperglycemia 03/2022 - 11/2014
9	Body Weight (Weight, Body) 01/2021 - 04/2007
5	Ketosis 01/2021 - 09/2007
5	Diabetes Mellitus 01/2021 - 01/2007
4	Weight Gain 01/2021 - 01/2003
3	COVID-19 06/2022 - 01/2021
2	Obesity 06/2022 - 01/2017
2	Infections 09/2021 - 09/2018
2	Overweight 01/2021 - 01/2017
2	Phobic Disorders (Phobia) 08/2011 - 08/2006
1	Coma (Comas) 01/2021
1	Latent Autoimmune Diabetes in Adults 01/2021
1	Nausea 01/2021
1	Vomiting 01/2021
1	Chronic Renal Insufficiency 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Genetic Risk Score 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Hyperkalemia 01/2019
1	Hypercholesterolemia 01/2019
1	Weight Loss (Weight Reduction) 09/2018
1	Diarrhea 09/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Disease Susceptibility (Diathesis) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 03/2015
1	Non-alcoholic Fatty Liver Disease 01/2015
1	Diabetes Complications 05/2013

Drug/Important Bio-Agent (IBA)

56	Insulin (Novolin)FDA Link 10/2021 - 01/2003
41	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 09/2005
12	Blood Glucose (Blood Sugar)IBA 01/2021 - 08/2003
11	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021 - 12/2017
10	Insulin Aspart (NovoLog)FDA Link 01/2021 - 08/2003
9	Insulin Glargine (Lantus)FDA Link 10/2020 - 06/2007
8	insulin degludecIBA 08/2020 - 02/2014
6	Hemoglobins (Hemoglobin)IBA 10/2022 - 11/2012
6	SodiumIBA 01/2022 - 01/2019
6	Sodium-Glucose Transport ProteinsIBA 01/2021 - 12/2017
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 06/2007
4	dapagliflozinIBA 01/2021 - 11/2017
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2018
4	Insulin Detemir (Levemir)FDA Link 01/2019 - 11/2003
4	CarbohydratesIBA 12/2017 - 11/2012
3	AntibodiesIBA 01/2020 - 07/2004
3	KetonesIBA 11/2019 - 01/2019
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2019 - 11/2011
3	Proteins (Proteins, Gene)FDA Link 11/2012 - 07/2005
2	SymportersIBA 01/2021 - 01/2019
2	AutoantibodiesIBA 01/2019 - 07/2004
2	Sodium-Glucose Transporter 1IBA 09/2018 - 09/2018
2	LipidsIBA 01/2017 - 04/2007
2	SuspensionsIBA 01/2017 - 06/2014
2	Isophane Insulin (NPH Insulin)FDA Link 12/2013 - 10/2007
2	Protamines (Protamine Sulfate)FDA Link 12/2013 - 06/2007
2	insulin glulisine FDA Link 03/2011 - 09/2005
2	Short-Acting InsulinIBA 01/2007 - 08/2003
1	VaccinesIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	AutoantigensIBA 10/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	AldosteroneIBA 01/2021
1	AngiotensinsIBA 01/2021
1	dasiglucagonIBA 01/2021
1	Glucagon (Glukagon)FDA Link 01/2021
1	ReninIBA 01/2021
1	InsulinsIBA 10/2020
1	empagliflozinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	AntigensIBA 01/2019
1	casein hydrolysateIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Dietary ProteinsIBA 01/2018
1	Caseins (Casein)FDA Link 01/2018
1	Liraglutide FDA Link 01/2017
1	Nicotine FDA Link 01/2017
1	insulin aspart drug combination insulin degludecIBA 12/2016
1	ElementsIBA 03/2015
1	Transaminases (Aminotransferases)IBA 01/2015
1	Insulin Lispro (Humalog)FDA Link 03/2011
1	C-PeptideIBA 08/2010
1	PPAR gammaIBA 07/2008
1	Lente Insulin FDA Link 06/2007
1	ZincIBA 06/2007
1	glimepiride (Amarel)FDA LinkGeneric 04/2007

Therapy/Procedure

36	Therapeutics 06/2022 - 06/2007
21	Glycemic Control 10/2022 - 08/2003
9	Injections 01/2021 - 08/2003
3	Artificial Pancreas 03/2014 - 02/2013
1	Investigational Therapies (Experimental Therapy) 03/2022
1	Immunotherapy 10/2021
1	Transition to Adult Care 01/2021
1	Drug Therapy (Chemotherapy) 10/2017
1	Skin Care 01/2016
1	Subcutaneous Injections 06/2015
1	Catheters 03/2015